03/01/2026
Quercetin is a plant-derived flavonoid widely studied for its antioxidant, anti-inflammatory, neuroprotective, antiviral, and senolytic properties, though its oral bioavailability is relatively low.
As a potential nootropic, it can cross the blood–brain barrier and has shown in preclinical studies the ability to support memory and learning, protect neurons from oxidative stress, and modulate pathways such as SIRT1 and Nrf2 that are involved in cellular resilience and reduced neuroinflammation, with possible relevance to neurodegenerative diseases.
Its antiviral effects appear to stem from
interfering with multiple stages of the viral life cycle, including viral entry, protease activity, and replication, with in vitro and limited in vivo evidence against viruses such as influenza, herpes simplex, and certain coronaviruses, and it has been explored as an adjunct in respiratory infections.
Additionally, quercetin is recognized for senolytic and senomorphic actions, meaning it can help selectively promote apoptosis of senescent (“zombie”) cells and suppress the pro-inflammatory SASP factors they release; these effects are sometimes enhanced when combined with dasatinib in experimental and early clinical settings for age-related conditions.
While promising, much of the strongest evidence remains preclinical, and clinical outcomes, optimal dosing, and long-term safety continue to be investigated.